Fever is a common presentation in clinical practice, often indicating an underlying infection. However, it can also be a symptom of numerous non-infectious conditions, making its diagnosis a complex process. This article aims to provide a comprehensive guide to the diagnostic approach to fever.
The initial evaluation of a febrile patient should include a thorough history and physical examination. The history should focus on the onset, duration, and pattern of fever, associated symptoms, recent travel or exposure history, and underlying health conditions. Physical examination should aim to identify signs of localized infection or systemic disease.
Based on the initial evaluation, appropriate laboratory investigations should be ordered. These may include complete blood count, blood cultures, urine analysis, and imaging studies. In some cases, more specialized investigations like serology or polymerase chain reaction (PCR) tests may be required.
In patients with persistent fever despite initial investigations, further evaluation may be needed. This includes consideration for less common causes of fever such as malignancies, autoimmune diseases, and drug-induced fever. Additionally, in immunocompromised patients, the differential diagnosis is broader and often includes opportunistic infections and non-infectious inflammatory conditions.
The treatment of fever should be directed at the underlying cause, if identified. Symptomatic management with antipyretics can be used, but should not replace the need for a thorough evaluation and targeted treatment. In cases where the cause of fever remains unknown, empirical treatment may be considered based on the most likely differential diagnoses.
The diagnostic approach to fever in clinical practice encompasses a comprehensive evaluation, appropriate investigations, and a targeted treatment approach. Understanding this process is essential for healthcare professionals to effectively manage febrile patients and optimize their clinical outcomes.
1.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
2.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
5.
Early breast cancer detection may be possible with a wearable ultrasound scanner.
1.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
2.
Tumor Evolution: Signaling, Plasticity, and Intratumor Heterogeneity in Cancer
3.
Essential Perspectives in Hematology and Patient Outcomes
4.
Decoding Hamartomas: Understanding Their Causes and Symptoms
5.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
5.
Signs and Symptoms of Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation